ATyr Pretax Profit Margin from 2010 to 2024
| LIFE Stock | USD 1.57 0.03 1.88% |
Pretax Profit Margin | First Reported 2010-12-31 | Previous Quarter (142.77) | Current Value (135.63) | Quarterly Volatility 39.78334597 |
Check ATyr Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ATyr main balance sheet or income statement drivers, such as Interest Expense of 2 M, Selling General Administrative of 12.3 M or Total Revenue of 335.4 K, as well as many exotic indicators such as Price To Sales Ratio of 225, Dividend Yield of 0.0 or PTB Ratio of 0.79. ATyr financial statements analysis is a perfect complement when working with ATyr Pharma Valuation or Volatility modules.
ATyr | Pretax Profit Margin |
Latest ATyr Pharma's Pretax Profit Margin Growth Pattern
Below is the plot of the Pretax Profit Margin of aTyr Pharma over the last few years. It is ATyr Pharma's Pretax Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in ATyr Pharma's overall financial position and show how it may be relating to other accounts over time.
| Pretax Profit Margin | 10 Years Trend |
|
Pretax Profit Margin |
| Timeline |
ATyr Pretax Profit Margin Regression Statistics
| Arithmetic Mean | (56.79) | |
| Coefficient Of Variation | (70.06) | |
| Mean Deviation | 21.98 | |
| Median | (56.31) | |
| Standard Deviation | 39.78 | |
| Sample Variance | 1,583 | |
| Range | 141 | |
| R-Value | (0.18) | |
| Mean Square Error | 1,651 | |
| R-Squared | 0.03 | |
| Significance | 0.53 | |
| Slope | (1.58) | |
| Total Sum of Squares | 22,158 |
ATyr Pretax Profit Margin History
About ATyr Pharma Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include ATyr Pharma income statement, its balance sheet, and the statement of cash flows. ATyr Pharma investors use historical funamental indicators, such as ATyr Pharma's Pretax Profit Margin, to determine how well the company is positioned to perform in the future. Although ATyr Pharma investors may use each financial statement separately, they are all related. The changes in ATyr Pharma's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on ATyr Pharma's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on ATyr Pharma Financial Statements. Understanding these patterns can help to make the right decision on long term investment in ATyr Pharma. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | (142.77) | (135.63) |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards ATyr Pharma in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, ATyr Pharma's short interest history, or implied volatility extrapolated from ATyr Pharma options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of ATyr Pharma Correlation against competitors. For information on how to trade ATyr Stock refer to our How to Trade ATyr Stock guide.Note that the aTyr Pharma information on this page should be used as a complementary analysis to other ATyr Pharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Complementary Tools for ATyr Stock analysis
When running ATyr Pharma's price analysis, check to measure ATyr Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ATyr Pharma is operating at the current time. Most of ATyr Pharma's value examination focuses on studying past and present price action to predict the probability of ATyr Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ATyr Pharma's price. Additionally, you may evaluate how the addition of ATyr Pharma to your portfolios can decrease your overall portfolio volatility.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Stocks Directory Find actively traded stocks across global markets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |
Is ATyr Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ATyr Pharma. If investors know ATyr will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ATyr Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.94) | Revenue Per Share 0.007 | Quarterly Revenue Growth (1.00) | Return On Assets (0.32) | Return On Equity (0.62) |
The market value of aTyr Pharma is measured differently than its book value, which is the value of ATyr that is recorded on the company's balance sheet. Investors also form their own opinion of ATyr Pharma's value that differs from its market value or its book value, called intrinsic value, which is ATyr Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ATyr Pharma's market value can be influenced by many factors that don't directly affect ATyr Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ATyr Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if ATyr Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ATyr Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.